Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

Q2 2022 13F Holders as of 6/30/2022

Type / Class
Equity / Common Stock, par value $0.00001 per share
Number of holders
53
Total Shares
14.6M
Shares change
-2.17M
Total reported value, excl. options
$54.4M
Value change
-$11.1M
Put/Call ratio
0
Number of buys
28
Number of sells
-44
Price
$3.72
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.